ACHE and early-onset autosomal dominant Alzheimer disease: The current treatment for Alzheimer’s disease (AD) is acetylcholinesterase (AChE) inhibitors, which partially block the degradation of ACh in the synapse and enable more of the neurotransmitter to reach and activate cholinergic receptors [64].